Trends in surgery for screen-detected and interval breast cancers in a national screening programme

British Journal of Surgery

Volumn 101, Issue 8, 2014, Pages 949-958

  Nederend, J ^a   Duijm, L E M ^c   Louwman, M W J ^b   Roumen, R M H ^d   Jansen, F H ^a   Voogd, A C ^e  

^a CATHARINA HOSPITAL   (Netherlands)

^b The Netherlands   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY; METHODOLOGY; MIDDLE AGED; NETHERLANDS; PAGET NIPPLE DISEASE; RADIOGRAPHY; RISK FACTOR; STATISTICS;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY; MIDDLE AGED; NETHERLANDS; RISK FACTORS;

EID: 84902240376     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9530     Document Type: Article

References (45)

1. Duijm LE, Groenewoud JH, Roumen RM, de Koning HJ, Plaisier ML, Fracheboud J,. A decade of breast cancer screening in the Netherlands: trends in the preoperative diagnosis of breast cancer. Breast Cancer Res Treat 2007; 106: 113-119.
2. Postma EL, Verkooijen HM, van Esser S, Hobbelink MG, van der Schelling GP, Koelemij R, et al. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat 2012; 136: 469-478.
3. van Riet YE, Jansen FH, van Beek M, van de Velde CJ, Rutten HJ, Nieuwenhuijzen GA,. Localization of non-palpable breast cancer using a radiolabelled titanium seed. Br J Surg 2010; 97: 1240-1245.
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 2011; 378: 1707-1716.
5. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241.
6. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992; 28A: 801-805.
7. Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009; 27: 4082-4088.
8. McGuire KP, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 2009; 16: 2682-2690.
9. Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009; 302: 1551-1556.
10. Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002; 9: 256-265.
11. Bani MR, Lux MP, Heusinger K, Wenkel E, Magener A, Schulz-Wendtland R, et al. Factors correlating with reexcision after breast-conserving therapy. Eur J Surg Oncol 2009; 35: 32-37.
12. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996; 348: 708-713.
13. Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 2009; 27: 1362-1367.
14. Sorbero ME, Dick AW, Beckjord EB, Ahrendt G,. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 2009; 16: 1597-1605.
15. Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM,. Are mastectomy rates really increasing in the United States? J Clin Oncol 2010; 28: 3437-3441.
16. Duijm LE, Groenewoud JH, Jansen FH, Fracheboud J, van Beek M, de Koning HJ,. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. Br J Cancer 2004; 91: 1795-1799.
17. Fracheboud J, de Koning HJ, Boer R, Groenewoud JH, Verbeek AL, Broeders MJ, et al. Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast 2001; 10: 6-11.
18. Duijm LE, Groenewoud JH, Fracheboud J, de Koning HJ,. Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters. J Natl Cancer Inst 2007; 99: 1162-1170.
19. ©-Mammography. 4th Edition. In ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. American College of Radiology: Reston, 2003; 7-175.
20. Gospardarowicz M, Wittekind C, Sobin L, (eds). AJCC Cancer Staging Manual (7th edn). Springer: New York, 2010.
21. Duijm LE, Groenewoud JH, de Koning HJ, Coebergh JW, van Beek M, Hooijen MJ, et al. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography. Eur J Cancer 2009; 45: 774-781.
22. Struikmans H, Nortier JW, Rutgers EJ, Zonderland HM, Bontenbal M, Elkhuizen PH, et al. [ Guideline 'Treatment of breast cancer 2008' (revision).] Ned Tijdschr Geneeskd 2008; 152: 2507-2511.
23. Nationaal Borstkanker Overleg Nederland. NABON Consensus Based Dutch Breast Cancer Guidelines; 2008. http://www.oncoline.nl [accessed 27 March 2014].
24. Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009; 209: 180-187.
25. Grady I, Gorsuch-Rafferty H, Hadley P,. Preoperative staging with magnetic resonance imaging, with confirmatory biopsy, improves surgical outcomes in women with breast cancer without increasing rates of mastectomy. Breast J 2012; 18: 214-218.
26. Kapoor NS, Eaton A, King TA, Patil S, Stempel M, Morris E, et al. Should breast density influence patient selection for breast-conserving surgery? Ann Surg Oncol 2013; 20: 600-606.
27. Mahmood U, Hanlon AL, Koshy M, Buras R, Chumsri S, Tkaczuk KH, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol 2013; 20: 1436-1443.
28. Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004; 100: 1823-1832.
29. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-2106.
30. Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, et al. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 2008; 15: 2542-2549.
31. Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M,. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol 2010; 17: 558-563.
32. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S,. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005; 241: 629-639.
33. Dunne C, Burke JP, Morrow M, Kell MR,. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009; 27: 1615-1620.
34. Smitt MC, Horst K,. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 2007; 14: 1040-1044.
35. Dillon MF, Hill AD, Quinn CM, McDermott EW, O'Higgins N,. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006; 13: 333-339.
36. Aziz D, Rawlinson E, Narod SA, Sun P, Lickley HL, McCready DR, et al., The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 2006; 12: 331-337.
37. Miller AR, Brandao G, Prihoda TJ, Hill C, Cruz AB Jr, Yeh IT,. Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol 2004; 86: 134-140.
38. National Breast Cancer Organization, The Netherlands. Breast Cancer. http://www.oncoline.nl [accessed 1 February 2013 ].
39. Jeevan R, Cromwell DA, Trivella M, Lawrence G, Kearins O, Pereira J, et al. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ 2012; 345: e4505.
40. van den Broek N, van der Sangen MJ, van de Poll-Franse LV, van Beek MW, Nieuwenhuijzen GA, Voogd AC,. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 2007; 105: 63-68.
41. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L,. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005; 11: 382-390.
42. Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA,. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. J Surg Oncol 2005; 90: 71-76.
43. Atkins J, Al Mushawah F, Appleton CM, Cyr AE, Gillanders WE, Aft RL, et al. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J Surg Res 2012; 177: 109-115.
44. Miglioretti DL, Gard CC, Carney PA, Onega TL, Buist DS, Sickles EA, et al. When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology 2009; 253: 632-640.
45. van der Heiden-van der Loo M, Ho VK, Damhuis RA, Siesling S, Menke MB, Peeters PH, et al. [ Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator.] Ned Tijdschr Geneeskd 2010; 154: A1984.